Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Medical Genetics
Published in: BMC Medical Genetics 1/2018

Open Access 01-12-2018 | Research article

Do polymorphisms in protein kinase catalytic subunit alpha-1 gene associated with cancer susceptibility? a meta-analysis and systematic review

Authors: Jialin Meng, Xinyao Fan, Meng Zhang, Zongyao Hao, Chaozhao Liang

Published in: BMC Medical Genetics | Issue 1/2018

Login to get access

Abstract

Background

Currently, several studies have demonstrated that PRKAA1 polymorphisms conduce to the development of cancer. PRKAA1 gene encodes the AMP-activated protein kinase summit-α1, and plays an important role in cell metabolism. Thus, we performed a systematic review and meta-analysis of all enrolled eligible case-control studies to obtain a precise correlation between PRKAA1 polymorphism and cancer susceptibility.

Methods

Extensive retrieve was performed in Web of Science, Google Scholar, PubMed, EMbase, CNKI and Wanfang databases up to August 26, 2018. Odds ratios (ORs) and 95% CIs were performed to evaluate the overall strength of the associations in five models, as well as in subgroup analyses, stratified by ethnicity, cancer type or source of control. Q-test, Egger’s test and Begg’s funnel plot were applied to evaluate the heterogeneity and publication bias. In-silico analysis was performed to demonstrate the relationship of PRKAA1 expression correlated with cancer tissues and survival time.

Results

Twenty-two case-control studies from 14 publications were enrolled, with 17,068 cases and 20,871 controls for rs13361707, and 2514 cases and 3193 controls for rs10074991. Overall, we identified that the PRKAA1 rs13361707 polymorphism is not significantly associated with cancer susceptibility under all five genetic models. For rs10074991, we revealed a significant decrease risk in allelic comparison model (B vs. A: OR = 0.774, 95% CI = 0.642–0.931, PAdjust = 3.376*10− 2), heterozygote comparison model (BA vs. AA: OR = 0.779 95%CI = 0.691–0.877, PAdjust = 9.86*10− 10;), and dominant genetic model (BB + BA vs. AA: OR = 0.697 95%CI = 0.533–0.912, PAdjust = 4.211*10− 2;). Evidence from TCGA database and GTEx projects indicated that the expression of PRKAA1 in gastric cancer tissue is higher, compared to normal stomach tissue, as well as it in breast cancer and esophageal squamous cell carcinoma. However, the Kaplan-Meier estimate showed that there is no significant difference of OS and RFS between the low and high PRKAA1 TPM groups in gastric cancer, breast cancer, and esophageal carcinoma.

Conclusions

To sum up, PRKAA1 rs13361707 polymorphism is not participant with the increased risk of cancer, while the A allele of PRKAA1 rs10074991 revealed a significant decrease risk.
Appendix
Available only for authorised users
Literature
1.
Arzumanyan A, Reis HM, Feitelson MA. Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat Rev Cancer. 2013;13(2):123–35.CrossRefPubMed
2.
Cocoş R, Schipor S, Nicolae I, Thomescu C, Raicu F. Role of COX-2 activity and CRP levels in patients with non-melanoma skin cancer. -765G>C PTGS2 polymorphism and NMSC risk. Arch Dermatol Res. 2012;304(5):335.CrossRefPubMed
3.
Stapleton D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, Teh T, House CM, Fernandez CS, Cox T, Witters LA, et al. Mammalian AMP-activated protein kinase subfamily. J Biol Chem. 1996;271(2):611–4.CrossRefPubMed
4.
Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res. 2007;100(3):328.CrossRefPubMed
5.
Hardie DG, Schaffer BE, Brunet A. AMPK: an energy-sensing pathway with multiple inputs and outputs. Trends Cell Biol. 2016;26(3):190–201.CrossRefPubMed
6.
Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005;1(1):15–25.CrossRefPubMed
7.
He XY, Liu XJ, Chen X, Bian LG, Zhao WG, Shen JK, Sun QF. Gambogic acid induces EGFR degradation and Akt/mTORC1 inhibition through AMPK dependent-LRIG1 upregulation in cultured U87 glioma cells. Biochem Biophys Res Commun. 2013;435(3):397–402.CrossRefPubMed
8.
Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, Birnbaum MJ, Thompson CB. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell. 2005;18(3):283–93.CrossRefPubMed
9.
Li M, Huang L, Qiu H, Fu Q, Li W, Yu Q, Sun L, Zhang L, Hu G, Hu J. Helicobacter pylori infection synergizes with three inflammation-related genetic variants in the GWASs to increase risk of gastric cancer in a Chinese population. PLoS One. 2013;8(9):e74976.CrossRefPubMedPubMedCentral
10.
Eom SY, Hong SM, Yim DH, Kwon HJ, Kim DH, Yun HY, Song YJ, Youn SJ, Hyun T, Park JS. Additive interactions betweenPRKAA1polymorphisms andHelicobacter pyloriCagA infection associated with gastric cancer risk in Koreans. Cancer Med. 2016;5(11):3236–335.CrossRefPubMedPubMedCentral
11.
Cai M, Dai S, Chen W, Xia C, Lu L, Dai S, Qi J, Wang M, Wang M, Zhou L. Environmental factors, seven GWAS-identified susceptibility loci, and risk of gastric cancer and its precursors in a Chinese population. Cancer Med. 2017;6(3):708–20.CrossRefPubMedPubMedCentral
12.
Campa D, Claus R, Dostal L, Stein A, Chang-Claude J, Meidtner K, Boeing H, Olsen A, Tjonneland A, Overvad K, et al. Variation in genes coding for AMP-activated protein kinase (AMPK) and breast cancer risk in the European prospective investigation on Cancer (EPIC). Breast Cancer Res Treat. 2011;127(3):761–7.CrossRefPubMed
13.
Sun Y, Gu J, Ajani JA, Chang DW, Wu X, Stroehlein JR. Genetic and intermediate phenotypic susceptibility markers of gastric cancer in Hispanic Americans: a case-control study. Cancer. 2014;120(19):3040.CrossRefPubMed
14.
Wu D, Li Y. Association of Helicobacter pylori infection and polymorphisms pf PSCA, PLCE1 and PRKAA1 with gastric cancer susceptibility[D]. Lanzhou: Lanzhou University; 2014.
15.
JJ Y, YY L, TT T NL, Zhu Y, Zou J, Gao J, Shen L. Risk prediction for early-onset gastric carcinoma: a case-control study of polygenic gastric cancer in Han Chinese with hereditary background. Oncotarget. 2016;7(23):33608–15.
16.
Dai N, Zheng M, Wang C, Ji Y, Du J, Zhu C, He Y, Zhu M, Zhu X, Sun M. Genetic variants at 8q24 are associated with risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Sci. 2014;105(6):731–5.CrossRefPubMedPubMedCentral
17.
Bonferroni CE: Teoria Statistica Delle Classi e Calcolo Delle Probabilità. Comm Firenze. 1936;8(1936):3-62.
18.
Handoll HH. Systematic reviews on rehabilitation interventions. Arch Phys Med Rehabil. 2006;87(6):875.CrossRefPubMed
19.
20.
Mantel N. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48.PubMed
21.
Tobias A, Campbell M: Modeling influenza epidemics in the relation between black smoke and total mortality. 1999.
22.
23.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101.CrossRefPubMed
24.
Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102.CrossRefPubMedPubMedCentral
25.
Shi Y, Hu Z, Wu C, Dai J, Li H, Dong J, Wang M, Miao X, Zhou Y, Lu F. A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1. Nat Genet. 2011;43(12):1215–8.CrossRefPubMed
26.
Song HR, Kim HN, Kweon SS, Choi JS, Shim HJ, Sang HC, Chung IJ, Park YK, Kim SH, Choi YD. Genetic variations in the PRKAA1 and ZBTB20 genes and gastric cancer susceptibility in a Korean population. Mol Carcinog. 2013;52(S1):155–60.CrossRef
27.
Kim YD, Yim DH, Eom SY, Moon SI, Yun HY, Song YJ, Youn SJ, Hyun T, Park JS, Kim BS, et al. Risk of gastric cancer is associated with PRKAA1 gene polymorphisms in Koreans. World J Gastroenterol. 2014;20(26):8592–8.CrossRefPubMedPubMedCentral
28.
Dong Y, Chen J, Chen Z, Tian C, Lu H, Ruan J, Yang W. Evaluating the Association of Eight Polymorphisms with Cancer susceptibility in a Han Chinese population. PLoS One. 2015;10(7):e0132797.CrossRefPubMedPubMedCentral
29.
Zhang Y, Zhang C, Yu X, Xu X, Wang L, Geng C, Dong Q. The correlation between polymorphisms of PRKAA1 and UNC5CL and susceptibility to gastric cancer. J Chin Clin Doct. 2016;44(10):21–5.
30.
Qiu LX, He J, Cheng L, Zhou F, Wang MY, Sun MH, Zhou XY, Li J, Guo WJ, Wang YN, et al. Genetic variant of PRKAA1 and gastric cancer risk in an eastern Chinese population. Oncotarget. 2015;6(40):42661–6.CrossRefPubMedPubMedCentral
31.
Wells M, Chande N, Adams P, Beaton M, Levstik M, Boyce E, Mrkobrada M. Meta-analysis: vasoactive medications for the management of acute variceal bleeds. Aliment Pharmacol Ther. 2012;35(11):1267–78.CrossRefPubMed
32.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–41.CrossRefPubMed
33.
Carling D, Thornton C, Woods A, Sanders MJ. AMP-activated protein kinase: new regulation, new roles? Biochem J. 2012;445(1):11–27.CrossRefPubMed
34.
Igata M, Motoshima H, Tsuruzoe K, Kojima K, Matsumura T, Kondo T, Taguchi T, Nakamaru K, Yano M, Kukidome D. Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression. Circ Res. 2005;97(8):837.CrossRefPubMed
35.
Kim E, Park J, Lim S, Choi JW, Kim HS, Seok H, Seo JK, Oh K, Lee D, Kim KT. Activation of AMP-activated protein kinase is essential for lysophosphatidic acid-induced cell migration in ovarian Cancer cells. J Biol Chem. 2011;286(27):24036.CrossRefPubMedPubMedCentral
36.
Krishan S, Richardson DR, Sahni S. Gene of the month. AMP kinase (PRKAA1). J Clin Pathol. 2014;67(9):758–63.CrossRefPubMed
37.
Ma X, Zhang J, Deng R, Ding S, Gu N, Guo X. Synergistic effect of smoking with genetic variants in the AMPKα1 gene on the risk of coronary artery disease in type 2 diabetes. Diabetes Metab Res Rev. 2015;30(6):483–8.CrossRef
38.
O'Neill LAJ, Hardie DG. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature. 2013;493(7432):346–55.CrossRefPubMed
39.
Sag D, Carling D, Stout RD, Suttles J. Adenosine 5′-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J Immunol. 2008;181(12):8633.CrossRefPubMed
40.
Macdonald TT, Horton MA, Choy MY, Richman PI. Increased expression of laminin/collagen receptor (VLA-1) on epithelium of inflamed human intestine. J Clin Pathol. 1990;43(4):313–5.CrossRefPubMedPubMedCentral
41.
Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR, Wang TC. Gastric Cancer originating from bone marrow-derived cells. Science (New York, NY). 2004;306(5701):1568.CrossRef
42.
Sun K, Hu P, Xu F. LINC00152/miR-139-5p regulates gastric cancer cell aerobic glycolysis by targeting PRKAA1. Biomed Pharmacother. 2018;97:1296–302.CrossRefPubMed
43.
44.
Zhu M, Jin G. Genetics and Molecular Signature of Gastric Cancer. In: Wei J, Liu B, editors. Personalized Management of Gastric Cancer. Singapore: Springer; 2017. p. 15-33.CrossRef
Metadata
Title
Do polymorphisms in protein kinase catalytic subunit alpha-1 gene associated with cancer susceptibility? a meta-analysis and systematic review
Authors
Jialin Meng
Xinyao Fan
Meng Zhang
Zongyao Hao
Chaozhao Liang
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Medical Genetics / Issue 1/2018
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/s12881-018-0704-8

Other articles of this Issue 1/2018

BMC Medical Genetics 1/2018 Go to the issue

Research article

Exploration of the association between FOXE1 gene polymorphism and differentiated thyroid cancer: a meta-analysis

Research article

Novel MEF2C point mutations in Chinese patients with Rett (−like) syndrome or non-syndromic intellectual disability: insights into genotype-phenotype correlation

Research article

A novel compound heterozygous variant of the SLC12A3 gene in Gitelman syndrome pedigree

CASE REPORT

A 73,128 bp de novo deletion encompassing the OPN1LW/OPN1MW gene cluster in sporadic Blue Cone Monochromacy: a case report

Research article

A unique homozygous WRAP53 Arg298Trp mutation underlies dyskeratosis congenita in a Chinese Han family

Research article

MiR-146a G/C rs2910164 variation in South African Indian and Caucasian patients with psoriatic arthritis